Efficacy and safety of didpeptidyl peptidase 4 inhibitors in patients with type 2 diabetes mellitus: a meta-analysis of 116 trials
21 May 2016 (00:00 - 00:00)
Organised by:
About the speaker

Karolinska Institute, Stockholm (Sweden)
9 More presentations in this session
Doctor D. Bodez (Creteil, FR)
Doctor M. Madeira (Coimbra, PT)
Doctor M. Casenghi (Rome, IT)
Access the full session
The Event
HEART FAILURE 2016
21 May - 24 May 2016
